The effects of sodium butyrate supplementation on the expression levels of PGC-1α, PPARα, and UCP-1 genes, serum level of GLP-1, metabolic parameters, and anthropometric indices in obese individuals on weight loss diet: a study protocol for a triple-blind, randomized, placebo-controlled clinical trial
Abstract Background Obesity is a multifaceted disease characterized by an abnormal accumulation of adipose tissue. Growing evidence has proposed microbiota-derived metabolites as a potential factor in the pathophysiology of obesity and related metabolic conditions over the last decade. As one of the...
Main Authors: | Parichehr Amiri, Seyed Ahmad Hosseini, Neda Roshanravan, Maryam Saghafi-Asl, Mitra Tootoonchian |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-08-01
|
Series: | Trials |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13063-022-06891-9 |
Similar Items
-
Sodium butyrate improves mitochondrial function and kidney tissue injury in diabetic kidney disease via the AMPK/PGC-1α pathway
by: Yue Yu, et al.
Published: (2023-12-01) -
Sodium butyrate alleviates free fatty acid-induced steatosis in primary chicken hepatocytes via the AMPK/PPARα pathway
by: Jiayi Ding, et al.
Published: (2024-04-01) -
Browning of Pig White Preadipocytes by Co-Overexpressing Pig PGC-1α and Mice UCP1
by: Lianjie Hou, et al.
Published: (2018-07-01) -
Role of Butyrate, a Gut Microbiota Derived Metabolite, in Cardiovascular Diseases: A comprehensive narrative review
by: Parichehr Amiri, et al.
Published: (2022-02-01) -
Stemness of Normal and Cancer Cells: The Influence of Methionine Needs and SIRT1/PGC-1α/PPAR-α Players
by: Youssef Siblini, et al.
Published: (2022-11-01)